- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 9/52 - Proteinases derived from bacteria
Patent holdings for IPC class C12N 9/52
Total number of patents in this class: 1116
10-year publication summary
90
|
87
|
88
|
95
|
87
|
83
|
84
|
87
|
97
|
50
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Novozymes A/S | 3311 |
76 |
President and Fellows of Harvard College | 5952 |
46 |
Allergan, Inc. | 2361 |
33 |
Ipsen Biopharm Limited | 261 |
22 |
The Broad Institute, Inc. | 1788 |
18 |
The Regents of the University of California | 19839 |
17 |
Massachusetts Institute of Technology | 10019 |
16 |
Amano Enzyme Inc. | 382 |
14 |
Children's Medical Center Corporation | 1853 |
14 |
Ipsen Bioinnovation Limited | 41 |
14 |
University of Washington | 2315 |
14 |
Hoffmann-La Roche Inc. | 3387 |
13 |
MERZ PHARMA GmbH & CO. KGaA | 618 |
13 |
Danisco US Inc. | 1100 |
12 |
Henkel AG & Co. KGaA | 10482 |
11 |
Biomadison, Inc. | 50 |
11 |
HANSA Biopharma AB | 68 |
11 |
ContraFect Corporation | 72 |
11 |
Endo Biologics Limited | 28 |
11 |
Board of Trustees of the University of Arkansas | 807 |
10 |
Other owners | 729 |